Skip to content

Clinical trials

Phase 3 Acute Coronary Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 3 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20093
20102
20111
20131
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Eli Lilly and Company2
Bayer1
Bristol-Myers Squibb1
General Hospital of Chinese Armed Police Forces1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Jiangsu vcare pharmaceutical technology co., LTD1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome14
Myocardial Infarction3
Angina, Unstable2
Cardiovascular Diseases2
Heart Diseases2
Atherosclerosis1
Coronary Artery Disease1
Coronary Disease1
Hyperlipidemias1
Myocardial Ischemia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.